Pearl River Capital, LLC Tg Therapeutics, Inc. Transaction History

Pearl River Capital, LLC

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$13.32 - $19.19 $730,695 - $1.05 Million
54,857 New
54,857 $975,000
Q4 2020

Feb 12, 2021
SELL
$25.27 - $54.9 $319,185 - $693,441
-12,631 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$18.49 - $27.24 $137,916 - $203,183
-7,459 Reduced 37.13%
12,631 $338,000
Q2 2020

Aug 10, 2020
BUY
$8.9 - $21.84 $178,801 - $438,765
20,090 New
20,090 $391,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email